Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip

Abstract

The lack of a robust pipeline of medical therapeutic agents for the treatment of heart disease may be partially attributed to the lack of in vitro models that recapitulate the essential structurefunction relationships of healthy and diseased myocardium. We designed and built a system to mimic mechanical overload in vitro by applying cyclic stretch to engineered laminar ventricular tissue on a stretchable chip. To test our model, we quantified changes in gene expression, myocyte architecture, calcium handling, and contractile function and compared our results vs. several decades of animal studies and clinical observations. Cyclic stretch activated gene expression profiles characteristic of pathological remodeling, including decreased α-to β-myosin heavy chain ratios, and induced maladaptive changes to myocyte shape and sarcomere alignment. In stretched tissues, calcium transients resembled those reported in failing myocytes and peak systolic stress was significantly reduced. Our results suggest that failing myocardium, as defined genetically, structurally, and functionally, can be replicated in an in vitro microsystem by faithfully recapitulating the structural and mechanical microenvironment of the diseased heart. organs on chips | mechanotransduction | muscular thin films | microarray | contraction

Microfluidic Genipin Deposition Technique for Extended Culture of Micropatterned Vascular Muscular Thin Films

“…Application to tissues requiring more complex patterning, such as the "brick wall" pattern of ventricular myocardial structure 27 , will require more elaborate microfluidic design. We have not seeded genipin-modified substrates with other cell types.…”

Regulatory aspects of small molecule drugs for heart regeneration

“…Combined with other state-of-the-art software, this system can measure the beat rate, amplitude, and other cardiac-specific parameters of these cells before and after the addition of pharmacological compounds at various concentrations. Recent advances in "heart on a chip" technologies may also provide a unique platform for the integration of iPSC-CMs in the drug discovery and screening process [99,100]. These semi-automated microfluidic-based systems allow for high-throughput pharmacological studies evaluating cardiac contractility on pre-fabricated chips.…”

Saving and Improving Lives in the Information Age

“…28,29 Another intriguing innovation is a novel bioengineering platform referred to as "organs on a chip." 30,31 In a "heart on a chip" model, neonatal rat cardiomyocytes are layered on a deformable thin elastic film, or chip. When the myocytes contract, they cause the film to bend.…”